http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102532326-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-66 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 |
| filingDate | 2011-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-102532326-B |
| titleOfInvention | A kind of human fiber plasminogen Kringle 5 variant of cancer target and its application |
| abstract | The invention belongs to biological technical field, the variant of human plasminogen Kringle 5 of specifically related to a kind of cancer target and its application, the method is by the built-up variant proteins of human plasminogen Kringle 5 of the part peptide fragment of CD13, connection peptide, human plasminogen Kringle 5, the variant proteins can produce good antineoplaston effect when being used alone and being used with chemotherapy drugs in combination.Present invention also offers a kind of method that the misfolded proteins are produced in Pichia pastoris. |
| priorityDate | 2011-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 119.